Apollomics

APLM · NASDAQ

$22.05−$0.3881 (−1.73%)TodayMarket closed ·
Prev close $22.44

Latest news

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Apollomics Inc. Announces $2.0 Million Bridge Financing

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseGlobe Newswire

    Nasdaq Resumes Trading in Apollomics Inc.

  • Press releaseGlobe Newswire

    Apollomics, Inc. Company Operational Continuity Update

  • Press releaseGlobe Newswire

    Nasdaq Halts Apollomics Inc., Ltd.

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress

  • Press releaseGlobe Newswire

    Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib

  • Press releaseGlobe Newswire

    Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

  • Press releaseGlobe Newswire

    Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement

  • Press releaseGlobe Newswire

    Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Dow Dips Over 300 Points; Walmart Raises FY25 Forecast

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • NewsAvi Kapoor

    Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Dow Falls 100 Points; Brady Posts Upbeat Results

  • Press releaseGlobe Newswire

    Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

  • Press releaseGlobe Newswire

    Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress

  • NewsAvi Kapoor

    S&P 500 Gains 1%; Home Depot Earnings Top Views

  • NewsAvi Kapoor

    Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.